Eight years after earning CE Mark authorization, Implantica AG has secured FDA Premarket Approval for RefluxStop.
NEWARK, DE / ACCESSWIRE / July 10, 2024 / The global gastroesophageal reflux disease (GERD) device market size is poised for significant growth, acquiring USD 1207.3 million in 2024. The demand for ...
As the holiday season approaches with larger meals and richer foods, occasional indigestion is common for many people.
More patients with bronchiectasis and Sjögren’s syndrome vs. only bronchiectasis had gastroesophageal reflux disease, a ...
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors ...
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market - Analysis By Drug Type, Distribution Channel, By Region, and By Country (2021 Edition ...
Stomach pain, acid reflux, belching, and difficulty digesting food… Do these symptoms sound familiar? If so, you may be ...
Gastroesophageal reflux disease (GERD) is causally associated with lung cancer risk, according to a study published online Dec. 8 in Cancer Medicine. Lin Li, from The Second Affiliated Hospital of ...